| For: | R RZ, Arias F, Bandres E, Cubedo E, Malumbres R, García-Foncillas J. Xeroderma pigmentosum group D 751 polymorphism as a predictive factor in resected gastric cancer treated withchemo-radiotherapy. World J Gastroenterol 2006; 12(37): 6032-6036 [PMID: 17009404 DOI: 10.3748/wjg.v12.i37.6032] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v12/i37/6032.htm |
| Number | Citing Articles |
| 1 |
Lucy Gossage, Srinivasan Madhusudan. Cancer Pharmacogenomics. Molecular Diagnosis & Therapy 2007; 11(6) doi: 10.1007/BF03256260
|
| 2 |
K R Fareed, P Kaye, I N Soomro, M Ilyas, S Martin, S L Parsons, S Madhusudan. Biomarkers of response to therapy in oesophago-gastric cancer. Gut 2009; 58(1) doi: 10.1136/gut.2008.155861
|
| 3 |
YONG-PING LIU, YANG LING, QIU-FENG QI, YA-PING ZHANG, CHANG-SONG ZHANG, CHANG-TAI ZHU, MEI-HUA WANG, YAO-DONG PAN. Genetic polymorphisms of ERCC1-118, XRCC1-399 and GSTP1-105 are associated with the clinical outcome of gastric cancer patients receiving oxaliplatin-based adjuvant chemotherapy. Molecular Medicine Reports 2013; 7(6) doi: 10.3892/mmr.2013.1435
|
| 4 |
Qiong Yang, Ying Wei, Yan-Xian Chen, Si-Wei Zhou, Zhi-Min Jiang, De-Rong Xie. Indirect Comparison Showed Survival Benefit from Adjuvant Chemoradiotherapy in Completely Resected Gastric Cancer with D2 Lymphadenectomy. Gastroenterology Research and Practice 2013; 2013 doi: 10.1155/2013/634929
|
| 5 |
Kakoli Das, Patrick Tan. New Advances on Disease Biomarkers and Molecular Targets in Biomedicine. 2013; doi: 10.1007/978-1-62703-456-2_7
|
| 6 |
H. Chu, D. Gu, M. Xu, Z. Xu, Y. Gong, W. Gong, Y. Tang, J. Zhou, N. Tong, Z. Zhang, J. Chen, M. Wang. A genetic variant in ERCC2 is associated with gastric cancer prognosis in a Chinese population. Mutagenesis 2013; 28(4) doi: 10.1093/mutage/get023
|
| 7 |
Jing Li, Martin H. Bluth, Andrea Ferreira-Gonzalez. Henry's Clinical Diagnosis and Management by Laboratory Methods. 2011; doi: 10.1016/B978-1-4377-0974-2.00072-5
|
| 8 |
Jiun‐I. Lai, Cheng‐Hwai Tzeng, Po‐Min Chen, Jen‐Kou Lin, Tzu‐Chen Lin, Wei‐Shone Chen, Jeng‐Kae Jiang, Huann‐Sheng Wang, Wei‐Shu Wang. Very low prevalence of XPD K751Q polymorphism and its association with XPD expression and outcomes of FOLFOX‐4 treatment in Asian patients with colorectal carcinoma. Cancer Science 2009; 100(7) doi: 10.1111/j.1349-7006.2009.01186.x
|
| 9 |
Ayse Basak Engin, Bensu Karahalil, Atilla Engin, Ali Esat Karakaya. DNA repair enzyme polymorphisms and oxidative stress in a Turkish population with gastric carcinoma. Molecular Biology Reports 2011; 38(8) doi: 10.1007/s11033-011-0690-9
|
| 10 |
Luis Alberto Henríquez-Hernández, Almudena Valenciano, Estefanía Herrera-Ramos, Marta Lloret, Alba Riveros-Perez, Pedro C. Lara. High-throughput genotyping system as a robust and useful tool in oncology: Experience from a single institution. Biologicals 2013; 41(6) doi: 10.1016/j.biologicals.2013.09.006
|
| 11 |
Emilia Balboa, Goretti Duran, Maria Jesus Lamas, Antonio Gomez-Caamaño, Catuxa Celeiro-Muñoz, Rafael Lopez, Angel Carracedo, Francisco Barros. Pharmacogenetic Analysis in Neoadjuvant Chemoradiation for Rectal Cancer: High Incidence of Somatic Mutations and their Relation with Response. Pharmacogenomics 2010; 11(6) doi: 10.2217/pgs.10.51
|
| 12 |
Yangkai Li, Zhensheng Liu, Hongliang Liu, Li-E Wang, Dongfeng Tan, Jaffer A. Ajani, Qing-Yi Wei, Xiaoping Miao. ERCC1 and ERCC2 Variants Predict Survival in Gastric Cancer Patients. PLoS ONE 2013; 8(9) doi: 10.1371/journal.pone.0071994
|
| 13 |
Karen De Souza, Suha Atabani, Srinivasan Madhusudan. Precision medicine in gastric cancer: where are we now?. Expert Review of Precision Medicine and Drug Development 2017; 2(4) doi: 10.1080/23808993.2017.1357431
|
| 14 |
Xi‐Dai Long, Yun Ma, Yong‐Zhi Huang, Yun Yi, Qiu‐Xiang Liang, Ai‐Min Ma, Li‐Ping Zeng, Guo‐Hui Fu. Genetic polymorphisms in DNA repair genes XPC, XPD, and XRCC4, and susceptibility to Helicobacter pylori infection‐related gastric antrum adenocarcinoma in Guangxi population, China. Molecular Carcinogenesis 2010; 49(6) doi: 10.1002/mc.20630
|
| 15 |
Ayse Basak Engin, Bensu Karahalil, Atilla Engin, Ali Esat Karakaya. Oxidative Stress,Helicobacter pylori, andOGG1Ser326Cys,XPCLys939Gln, andXPDLys751Gln Polymorphisms in a Turkish Population with Colorectal Carcinoma. Genetic Testing and Molecular Biomarkers 2010; 14(4) doi: 10.1089/gtmb.2009.0195
|
| 16 |
Christina Perry, Rebeka Sultana, Srinivasan Madhusudan. DNA Repair in Cancer Therapy. 2012; doi: 10.1016/B978-0-12-384999-1.10012-5
|
| 17 |
Hee Seung Kim, Mi-Kyung Kim, Hyun Hoon Chung, Jae Weon Kim, Noh Hyun Park, Yong Sang Song, Soon Beom Kang. Genetic polymorphisms affecting clinical outcomes in epithelial ovarian cancer patients treated with taxanes and platinum compounds: A Korean population-based study. Gynecologic Oncology 2009; 113(2) doi: 10.1016/j.ygyno.2009.01.002
|
| 18 |
Delphine Borchiellini, Marie-Christine Etienne-Grimaldi, Juliette Thariat, Gérard Milano. The impact of pharmacogenetics on radiation therapy outcome in cancer patients. A focus on DNA damage response genes. Cancer Treatment Reviews 2012; 38(6) doi: 10.1016/j.ctrv.2012.02.004
|